Target alteration can occur through various mechanisms, including genetic mutations, gene amplification, chromosomal translocations, and epigenetic changes. For example, mutations in the EGFR gene can lead to uncontrolled cell proliferation in non-small cell lung cancer. Similarly, amplification of the HER2 gene is often observed in certain types of breast cancer, leading to increased expression of the HER2 protein and promoting tumor growth.
